Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Suboxone receives approval recommendation in Europe

July 31, 2006

Oral nalmefene demonstrates positive results in pilot smoking cessation study

July 28, 2006

European CHMP hands down positive opinion for Exjade

July 5, 2006

Valera seeks to begin clinical studies of VP-004 naltrexone implant

June 29, 2006

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

June 29, 2006

Studies of NRP-104 pharmacokinetics, abuse potential reported

June 29, 2006

Preliminary results from phase II studies of cocaine vaccine TA-CD

June 28, 2006

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

June 27, 2006

Novel human anticocaine monoclonal antibody limits cocaine distribution to the brain

June 26, 2006

bPiDDB blocks nicotine-induced dopamine release in the nucleus accumbens

June 26, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026